NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Endocrinology


Return to Library

Free Endocrinology Articles


New life sciences research from Sheffield Children's Hospital described



2009 AUG 4 - (NewsRx.com) -- According to a study from Sheffield, the United Kingdom, "Newborn screening is evolving very rapidly. Geographical coverage is expanding, particularly for common disorders such as congenital hypothyroidism."

"New technologies, particularly tandem mass spectrometry and high throughput mutation analysis, have increased greatly the range of disorders which could be covered. However, these new possibilities are being exploiting at very different rates in different countries. This is due in part to the different ways in which generally-accepted screening criteria, based on the ten principles of Wilson and Jungner, are being interpreted and applied to policy. The appropriate management of some of the conditions newly-detectable by screening also remains controversial and there is a pressing need to align screening policy and clinical practice," wrote R.J. Pollitt and colleagues, Sheffield Children's Hospital.

The researchers concluded: "Critical analysis and careful collection of data on an international basis are required to resolve these issues."

Pollitt and colleagues published the results of their research in the Journal of Inherited Metabolic Disease (Newborn blood spot screening: New opportunities, old problems. Journal of Inherited Metabolic Disease, 2009;32(3):395-399).

For additional information, contact R.J. Pollitt, Sheffield Children's Hospital, Newborn Screening Laboratory, Sheffield S10 2TH, S Yorkshire, UK.

The publisher of the Journal of Inherited Metabolic Disease can be contacted at: Springer, Van Godewijckstraat 30, 3311 Gz Dordrecht, Netherlands.

Keywords: United Kingdom, Sheffield, Life Sciences, Endocrinology, Congenital Hypothyroidism, Metabolic Disease, Inherited Metabolic Disease, Mass Spectrometry, Sheffield Children's Hospital.

This article was prepared by Life Science Weekly editors from staff and other reports. Copyright 2009, Life Science Weekly via NewsRx.com.

NewsRx NewsRx NewsRx
-----------------------
PR Login